0001140361-15-012509.txt : 20150318 0001140361-15-012509.hdr.sgml : 20150318 20150318171205 ACCESSION NUMBER: 0001140361-15-012509 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150318 DATE AS OF CHANGE: 20150318 EFFECTIVENESS DATE: 20150318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-236187 FILM NUMBER: 15710802 BUSINESS ADDRESS: STREET 1: 205 EAST 42ND STREET STREET 2: SUITE 15-048 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 205 EAST 42ND STREET STREET 2: SUITE 15-048 CITY: NEW YORK STATE: NY ZIP: 10017 D 1 primary_doc.xml X0707 D LIVE 0001636651 Ovid Therapeutics Inc. 205 EAST 42ND STREET SUITE 15-048 NEW YORK NY NEW YORK 10017 212-776-4381 DELAWARE None None Corporation true 2014 Matthew J. During 205 East 42nd Street Suite 15-048 New York NY NEW YORK 10017 Executive Officer Director Jeremy M. Levin 205 East 42nd Street Suite 15-048 New York NY NEW YORK 10017 Executive Officer Director Mark Feldberg 205 East 42nd Street Suite 15-048 New York NY NEW YORK 10017 Director Other Technology Decline to Disclose 06b false 2014-10-10 false true false 0 5060000 5060000 0 false 5 0 0 0 false Ovid Therapeutics Inc. /s/ Matthew J. During Matthew J. During President 2015-03-16